Given these findings, stimulating S1R appears to be a beneficial strategy in treating neurodegenerative diseases, as it promotes the autophagy mechanism and facilitates the degradation of dysfunctional cellular proteins and organelles (Figure 3). This evidence concerns the gene TMBIM4 and neurodegenerative disease.